Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 460301 - 460320 out of 495680 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Switzerland | (L01FA01) rituximab | MabThera subkutan, Inj Lös 1600 mg/13.4 ml s.c., Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell | RochePharma(Schweiz)AG |
| Switzerland | (L01FC01) daratumumab | Darzalex, Inf Konz 100 mg/5ml (alt), Durchstf 5 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagAG |
| Switzerland | (L01FC01) daratumumab | Darzalex, Inf Konz 100 mg/5ml, Durchstf 5 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagAG |
| Switzerland | (L01FC01) daratumumab | Darzalex, Inf Konz 400 mg/20ml (alt), Durchstf 20 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagAG |
| Switzerland | (L01FC01) daratumumab | Darzalex, Inf Konz 400 mg/20ml, Durchstf 20 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagAG |
| Switzerland | (L01FC01) daratumumab | Darzalex SC, Inj Lös 1800 mg/15ml, Durchstf 15 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagAG |
| Switzerland | (L01FC02) isatuximab | Sarclisa, Inf Konz 100 mg/5ml, Durchstf 5 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Sanofi-Aventis(Suisse)SA |
| Switzerland | (L01FC02) isatuximab | Sarclisa, Inf Konz 500 mg/25ml, Durchstf 25 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Sanofi-Aventis(Suisse)SA |
| Switzerland | (L01FD01) trastuzumab | Herzuma, Trockensub 440 mg c Solv, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | iQoneHealthcareSwitzerlandSA |
| Switzerland | (L01FD01) trastuzumab | Kanjinti, Trockensub 440 mg c Solv, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AmgenSwitzerlandAG |
| Switzerland | (L01FD01) trastuzumab | Herceptin subkutan, Inj Lös 600 mg/5 ml subkutan, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | RochePharma(Schweiz)AG |
| Switzerland | (L01FD01) trastuzumab | Trazimera, Trockensub 440 mg c Solv, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | PfizerAG |
| Switzerland | (L01FD01) trastuzumab | Herzuma, Trockensub 150 mg, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | iQoneHealthcareSwitzerlandSA |
| Switzerland | (L01FD01) trastuzumab | Kanjinti, Trockensub 150 mg, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AmgenSwitzerlandAG |
| Switzerland | (L01FD01) trastuzumab | Ogivri, Trockensub 150 mg, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | MediusAG |
| Switzerland | (L01FD01) trastuzumab | Trazimera, Trockensub 150 mg, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | PfizerAG |
| Switzerland | (L01FD01) trastuzumab | Ogivri, Trockensub 440 mg, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | MediusAG |
| Switzerland | (L01FD03) trastuzumab emtansine | Kadcyla, Inf Konz 100 mg, Vial 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RochePharma(Schweiz)AG |
| Switzerland | (L01FD03) trastuzumab emtansine | Kadcyla, Inf Konz 160 mg, Vial 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RochePharma(Schweiz)AG |
| Switzerland | (L01FD04) trastuzumab deruxtecan | Enhertu, Inf Konz 100 mg, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | DaiichiSankyo(Schweiz)AG |
Pages
